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The purpose of this review is to systematically appraise the peer-reviewed literature about clustered forms of
psychopathology and to present a framework that can be useful for studying comorbid psychiatric disorders. The
review focuses on four of the most prevalent types of mental health problems: anxiety, depression, conduct
disorder, and substance abuse. The authors summarize existing empirical research on the distribution of
concurrent and sequential comorbidity in children and adolescents and in adults, and they review existing
knowledge about exogenous risk factors that influence comorbidity. The authors include articles that used
a longitudinal study design and used psychiatric definitions of the disorders. A total of 58 articles met the inclusion
criteria and were assessed. Current evidence demonstrates a reciprocal, sequential relation between most
comorbid pairs, although the mechanisms that mediate such links remain to be explained. Methodological
concerns include the inconsistency of measurement of the disorders across studies, small sample sizes, and
restricted follow-up times. Given the significant mental health burden placed by comorbid disorders, and their high
prevalence across populations, research on the key risk factors for clustering of psychopathology is needed.
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INTRODUCTION
Psychiatric comorbidity is the presence, simultaneously
or in sequence, of two or more disorders in an individual
within a certain time period (1, 2). Psychiatric comorbidity
is a prevalent phenomenon across age groups and types of
populations (3–5). The Epidemiologic Catchment Area
(ECA) Survey found that 35 percent of respondents with
at least one lifetime disorder had one or more additional
disorders during their lifetime (6); the National Comorbidity
Survey Replication found that 27.7 percent of the respond-
ents had two or more disorders during their lifetime (7).
Understanding psychiatric comorbidity has important re-
search, clinical, and nosologic implications. From a research
perspective, epidemiologic research conducted on isolated
disorders may underestimate the burden imposed by mental
health problems because this group may represent a select
portion of the population that suffers from psychiatric dis-
orders (8). Documenting the relation between key psychiat-
ric disorders over the life course can provide a more
accurate assessment of the psychiatric burden experienced
by different population groups.
With respect to clinical concerns, comorbidity is associ-
ated with more severe psychiatric symptoms, more func-
tional disability, longer illness duration, less social
competence, and higher service utilization (9–11). Given
the high prevalence of comorbidity and its clinical conse-
quences, research efforts that aim to better understand the
patterns of comorbidity over time are clearly essential to
help guide its prevention.
Investigation into the distribution of comorbidity across
key psychiatric disorders can also help us elucidate the
structure of phenotypic psychopathology. The cooccurrence
of disorders has called into question the validity of current
categorical classifications of mental disorders, with critics
suggesting that a dimensional approach to classifying co-
morbid disorders is more appropriate (12). Studying comor-
bid patterns can thus help us discern commonalities and
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distinctions in the developmental pathways of comorbid
disorders and in the etiologic profiles of each comorbid
disorder—elements that will provide the basis to understand
whether the disorders are different expressions of the same
underlying disturbance or are distinct disorders in their own
right (13).
This review aims to examine current knowledge on the
epidemiology of clustered forms of psychopathology over
the life course, focusing on four of the most common mental
disorders: anxiety, depression, conduct disorder, and sub-
stance abuse. According to the National Comorbidity Sur-
vey Replication, 28.8 percent of the US population suffered
from an anxiety disorder sometime in their life, whereas
20.8 percent suffered from a mood disorder, 14.6 percent
had a substance use disorder, and 9.5 percent presented
symptoms of conduct disorder (7). The cooccurrence of
these conditions has been consistently documented in clin-
ical and population samples (5).
This paper systematically reviews comorbidity studies
within a life course framework, focusing exclusively on pro-
spective population-based studies. This presents a novel ap-
proach to address comorbidity and enables us to study
similarities and differences in comorbidity patterns at key
life stages as well as to understand how the normative de-
velopmental trajectories of disorders may influence the
magnitude of comorbidity from childhood to adulthood.
Focusing on population-based studies overcomes one of
the key limitations of clinical studies: selection bias that
may determine the patterns of comorbidity observed in the
sample.
REVIEW OF THE LITERATURE
This review encompasses the peer-reviewed literature
published between 1970 and 2007. We limited our review
to these years to reflect current thinking about psychiatric
comorbidity and to include studies that use methods consid-
ered standard today. The literature reviewed was identified
through the Social Science Citation Index and Science
Citation Index, and it covered studies about concurrent and
sequential comorbidity between anxiety, depression, sub-
stance use/abuse, and conduct disorder. We restricted our
review to longitudinal, population-based studies that pro-
vided information about the temporal associations between
disorders. As stated by Kraemer et al. (14), cross-sectional
studies, particularly those that use lifetime prevalence with
mixed-age samples to estimate comorbidity, run the risk of
identifying instances of ‘‘pseudocomorbidity’’ when no real
comorbidity exists.
The literature on comorbidity is vast and encompasses
many different fields, from medicine to public health to
psychology. We restricted our review to psychiatric defini-
tions of the disorders because a wider review would have
been beyond the scope of this project. For example, for
conduct disorder, we considered measurement of symptoms
or diagnoses of conduct disorder, oppositional defiant dis-
order, and antisocial personality disorder but not aggression
or delinquency. The search was limited to English-language
studies in biomedical research. Keywords and terms used
for the search included primarily the following: 1) for sub-
stance abuse: substance abuse, alcohol abuse, drug abuse,
cannabis, cocaine, heroin, street drugs, smoking, injection
drug use; 2) for depression: depression, depression symp-
tomatology, depression symptoms, mood disorders; 3) for
conduct disorder: conduct disorder, antisocial personality
disorder, antisocial, opposition defiant disorder, externaliz-
ing behavior/disorder; 4) for anxiety disorder: anxiety, anx-
iety symptomatology, anxiety symptoms, internalizing
disorder; and 5) for comorbidity: comorbidity, joint trajec-
tories, discordant trajectories, concurrent, cooccurrence,
risk pathways, chain of risk, launch factors, transitions, risk
pathways.
FINDINGS
In this paper, we review concurrent and sequential comor-
bidity between the four disorders, and we present available
data on concurrent comorbidity, sequential comorbidity, and
contributions of each disorder to the deflection of develop-
mental trajectories of the other three disorders. This review
covers 58 studies, including those using child and adoles-
cent samples, and then adult samples, to present available
knowledge on comorbidity at key life stages. The original
search provided 103 articles, of which 45 were removed
because of the absence of a prospective study design.
Although studies such as Kessler et al.’s (15) on the National
Comorbidity Survey Replication or the cross-national com-
parison of comorbidity conducted by Merikangas et al. (16)
offer groundbreaking data on the distribution of comorbid
disorders in population-based samples, they were not in-
cluded because they used retrospective measures of disorder
onset in cross-sectional study designs.
The studies reviewed here (summarized in tables 1 and 2)
approach the issue of causality between comorbid disorders
by investigating the relative timing of the onset of each
disorder and the impact that the prevalence of one disorder
has on the course of the other. The strength of the causal link
depends on whether the cooccurrence of the disorders per-
sists after accounting for common risk factors (3, 17).
Anxiety and substance use
The evidence on the link between anxiety and substance
use is mixed: most studies have been cross-sectional or
retrospective in design and used dimensional rather than
diagnostic measures of anxiety. The few existing prospec-
tive, diagnostic studies (18–22) propose several alternative
causal associations between anxiety and substance abuse:
1) individuals with an anxiety disorder may be more likely
to develop or sustain a substance use disorder, in part as
a way to manage the symptoms of anxiety (21, 23, 24);
2) having an anxiety disorder may reduce or delay the onset
of behavioral problems such as substance abuse either be-
cause of the high level of anxious social cognitions that
serve as a reminder of the negative consequences of the
behavior or because of behavioral inhibition that results
from anxiety disorders (25); 3) substance use may exert
physiologic effects that increase vulnerabilities to anxiety
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disorders; or 4) a third variable may promote the develop-
ment or maintenance of both (20).
Children and adolescents. Childhood and adole-
scence is a critical time to investigate the timing of onset
of the comorbid disorders since anxiety has a relatively
early age at onset (26). Few studies have looked prospec-
tively at the link between anxiety and substance abuse
among the younger age groups. Several studies have found
support for the ‘‘self-medication’’ thesis: that persons with
anxiety use alcohol and drugs to suppress their anxiety
symptoms (18, 22, 27–29). Costello et al. (18) found that
anxiety predicted later substance use disorders among a rep-
resentative population sample of adolescent girls, but not
among boys. However, several studies have also found sup-
port for the reverse association, in which substance depen-
dence promotes the development of anxiety (20, 21).
A particularly compelling study that followed children over
21 years and obtained prospective reports of anxiety and
substance dependence found that the association between
anxiety and substance dependence was largely or entirely
noncausal, while substance dependence predicted anxiety
disorder at follow-up. Finally, some evidence also exists
for a negative relation between anxiety and substance use:
Pardini et al. (25) followed the Pittsburgh Youth Study sam-
ple of boys from early adolescence to young adulthood, and
they found that higher levels of anxiety/withdrawal were
inversely related to symptoms and diagnoses of alcohol
use disorder; a cohort study of a representative population
sample aged 9–13 years at baseline found that anxiety pre-
dicted a later onset of smoking (30).
Lack of conclusive evidence is due to the heterogeneity of
substance use and anxiety subtypes examined in the few
available population-based studies: associations may differ
between subtypes. Kaplow et al. (28) proposed that, in stud-
ies that consider anxiety as a general syndrome and fail to
differentiate within its dimensions, the opposing functions
of different types of anxiety may offset each other, resulting
in null findings. In fact, Kaplow et al. found opposing effects
for generalized anxiety disorder and separation anxiety dis-
order: whereas generalized anxiety disorder was positively
associated with alcohol use initiation, separation anxiety
disorder resulted in a lower risk of onset of alcohol use.
A study of 2,548 adolescents in Germany also found that
the association depended on the type of anxiety disorder
examined; although the seven lifetime anxiety disorders
taken as a set predicted subsequent onset of hazardous
use, abuse, and persistence, only panic and social phobia
were independent predictors of hazardous use and abuse
and the persistence of an alcohol use disorder (22).
Adults. Studies conducted among adults provide sup-
port for a potential reciprocal relation between anxiety
and substance abuse. A study of 454 college students fol-
lowed over 7 years, for example, found that having an anx-
iety disorder was associated with 3.5–5 times higher odds of
developing a new alcohol dependence, while the odds of
developing a new anxiety disorder were about four times
higher for those diagnosed with alcohol dependence in pre-
vious years (24). The direction of the relation between anx-
iety and substances may depend on the type of substance.
The Kushner et al. study (24) was limited by use of a select
population that may have a more similar mental health sta-
tus than the general population. In a study of a random
sample of the adult population, however, Newcomb et al.
(31) also found a bidirectional relation between anxiety and
substance use: polydrug problems in young adulthood in-
creased anxiety in adulthood, but anxiety was actually as-
sociated with fewer cocaine problems later in life—possibly
because individuals who experience high levels of arousal
would be less likely to use a drug that exacerbated that
arousal.
Depression and substance abuse
Depressive symptoms are associated with substance use
disorders throughout adolescence and adulthood (25). As
with anxiety, the directionality and causal nature of the as-
sociation remains in question: depression and substance use
disorders may be linked through common confounding fac-
tors, or the association may be causal—either that alcohol
and illegal substances are used as a form of self-medication
to manage symptoms of depression or that substance use
may increase vulnerability to depression through behavioral
changes or neurophysiologic alterations (32).
Children and adolescents. Several studies have re-
ported that depression and substance abuse tend to cooccur
in adolescence (18, 19, 21, 33–35). In a study of high school
students in western New York, Windle and Davies (35)
found that 24–27 percent of adolescents identified as de-
pressed also met the criteria for heavy drinking, whereas
Rao et al. (34) found that 21.1 percent of adolescent women
with depression also had a substance use disorder. The na-
ture of the association between depression and substance
abuse among adolescents remains in question. Several stud-
ies found that depressed adolescents were more vulnerable
to substance use; this association has been found for mari-
juana (27), smoking (33), alcohol abuse (25), and substance
abuse problems (36). Fergusson et al. (33) and Pardini et al.
(25), authors of two of the most promising studies on issues
of depression–substance abuse comorbidity among adoles-
cents, highlight the lack of conclusive evidence on this is-
sue. Fergusson et al. followed a birth cohort of 1,265
children from birth to age 21 years and found that major
depression was associated with increased rates of daily
smoking and nicotine dependence, although the association
could be due to confounders that affected the development
of both outcomes. Pardini et al. also followed up 506 boys
until young adulthood and found that increased depression
in early adolescence was associated with more alcohol use
disorder symptoms and alcohol abuse and dependence di-
agnoses by young adulthood, but only for boys with high
levels of conduct problems.
Evidence also exists to support the hypothesis that sub-
stance use may increase vulnerability to depression.
Hayatbakhsh et al. (21) followed a comparable cohort of
3,239 children up to age 21 years and found that symptoms
of depression in childhood did not predict use of marijuana,
but use of marijuana was associated with depression.
A small study of 155 women aged 17–19 years also found
that substance use disorders predicted worse depression
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TABLE 1. Population studies on comorbid patterns between substance abuse, anxiety, depression and conduct disorder among children and adolescents






1,265 children (635 males,
630 females) from
Christchurch, New Zealand
21 years CIDI* and custom-written survey
items used; alcohol dependence:




anxiety disorders, panic disorder,
agoraphobia, social phobia, and
specific phobia): CIDI diagnostic
to assess DSM-IV criteria
Young people with anxiety disorders are
at increased risk of substance
dependence; association is largely
noncausal and is explained by 1)
presence of fixed childhood and family
factors associated with both anxiety
and substance dependence; and 2)
time-dynamic associations including
lagged effects of substance dependence
and development of comorbid
depression. OR* of substance
dependence associated with anxiety







14–24 years in Munich,
Germany
4 years Diagnostic assessment based
on the computer-assisted








Anxiety disorders are significant
predictors of the subsequent onset
and persistence of regular and
hazardous alcohol use and alcohol
use disorders. Panic disorder and
social phobia are the only anxiety







307 monozygotic and 185
dizygotic same-sex male




4 years Substance use based on ratings
given by multiple informants
during a home interview using
the DSM-based CAPA,* conduct
disorder measured with a
composite rating based on
child’s response to CAPA
symptoms, a diagnosis
of conduct disorder and
oppositional defiant disorder,
and ratings on the Olweus
aggression scale; depression
based on CAPA symptoms
associated with a diagnosis
of major depressive episode
Among boys, the cross-lagged
correlations between conduct
disturbance and substance use and
between substance use and depression
were approximately equal, indicating
that a common factor contributed to
these behaviors; among girls, there were
differences in the pattern of the cross-
lagged correlations for conduct disorder
and depression, substance use and
conduct disorder, and substance use
and depression, indicating that conduct
disorder preceded substance use and
that depression followed substance use.
Among girls, the cross-lagged
associations were also consistent with






Birth cohort of 1,265 children
(635 males, 630 females)
born in Christchurch,
New Zealand in mid-1977
Assessed at birth,
4 months, 1 year,
annually to age
16 years, and
at ages 18 and
21 years
Smoking based on written survey,
nicotine dependence based on
DSM-III-R* criteria at age
16 years and DSM-IV criteria
at ages 18 and 21 years; major
depression measured with
DISC* with DSM-III-R criteria
at age 16 years and CIDI with
DSM-IV criteria at ages
18 and 21 years
Major depression was associated with
increased rates of daily smoking
(IRR* 5 1.19 (95% CI: 1.03, 1.39)).
and elevated rates of nicotine








































155 women aged 17–19
years recruited from three






Axis I disorders assessed with the
Structured Clinical Interview for
DSM-III-R; self-reported
depressive symptoms
assessed with the Beck
Depression Inventory; self-
reported problems of substance
use assessed at the end of
follow-up with the Rutgers
collegiate Substance Abuse
Screening Test
Depression and substance use disorder
were related concurrently; major
depressive disorder and substance
use disorder were significantly
associated in follow-up; substance use
disorder problem score and Beck
Depression Inventory (self-reported
depressive symptoms) during follow-up
were also correlated. Major depressive
disorder before the study did not predict
substance use disorder during the
follow-up period, whereas prior
substance use disorder did predict
major depressive disorder at follow-up.
Prior substance use disorder also
predicted the worst Beck Depression






975 high school students
from western New York
State in the first wave,
220 added in the second
wave; average age, 15.54
years (data collected from
primary caregivers: 90%
mothers)









drinks in the last 30 days
24–27% of adolescents identified as
depressed met the criteria for heavy
drinking (33–37% of boys, 16–18.5% of
girls); 23–27% of adolescent heavy
drinkers were depressed (18–20% of
boys, 27–33% of girls). Approximately
5% of participants had depression and
were heavy drinkers at either wave.
The mixed drinking and depression
group showed the lowest stability
between time 1 and time 2: only 20%
of those in the mixed group at time






900 adolescents (9th, 10th,
and 11th graders) from
Boston, Massachusetts
3 years Depressive symptoms measured
with CES-D Scale; measures
of alcohol and drug use
adapted from Monitoring
the Future studies
Rate of cooccurring depression and
substance use problems was 4% (n 5 39);
those with prior substance problems were
more than twice as likely to develop
cooccurring problems (9%) at time 2






1,420 children in the total
study from western North
Carolina; for this analysis,
only 936 included who
completed child or




as well as reported alcohol
use at all four time points
4 years CAPA used to assess
psychiatric symptoms
Children with early symptoms of
generalized anxiety were found to be
at increased risk for initiation of alcohol
use (OR 5 1.14 (95% CI: 1.03, 1.25)),
whereas children with early symptoms
of separation anxiety were at decreased
risk (OR 5 0.71 (95% CI: 0.51, 0.94));
depressive symptomatology was
associated with increased risk for
initiation of alcohol use in adolescence






3,239 Australian young adults Birth to age
21 years
Anxiety and depression symptoms
in the last 6 months measured
in the 21-year follow-up by
using the Young Adult Self-
Report; cannabis use
retrospectively assessed,
occasional use 5 use of
cannabis once a month or not
in the past month, frequent
use 5 use of cannabis every
day or every few days
Frequent use of cannabis, either without
(OR 5 2.1 (95% CI: 1.1, 4.0)) or with
(OR 5 2.7 (95% CI: 1.8, 4.1)) use of
other illicit drugs, predicts more than a
twofold increase in anxiety and depression
in young adults. No association was found
between symptoms of anxiety and
depression at age 14 years and either
occasional or frequent use of cannabis by
young adults. Frequent use of cannabis
and early onset of use are associated with




























































adolescents in Ann Arbor,
Michigan, who were at
risk of dropping out of school
4 years Depressive symptoms assessed
with items from the Brief
Symptom Inventory; anxiety
symptoms assessed with six
items from the Brief Symptom
Inventory
Adolescents who presented consistently
high levels of depressive symptoms
were more likely to report higher anxiety
symptoms compared with adolescent
members of other trajectories.
Adolescents whose depressive
symptoms followed the decreasing
trajectory had higher levels of anxiety







young adults aged 14–24




Munich-CIDI used to diagnose
by using DSM-IV criteria; social
anxiety disorder defined as
meeting DSM-IV criteria per
the Munich-CIDI diagnostic
criteria; depressive disorder
defined as meeting DSM-IV
criteria for one or more
episodes of major depression
or dysthymia
Persons with a combination of social
anxiety disorder and depression are at
the greatest risk of depression in early
adulthood. Persons with depression
and social anxiety disorder (current or
previous) were significantly more likely
(OR 5 8.7 (95% CI: 4.5, 16.8)) than
persons with no mental disorder to
have experienced a depressive






young adults aged 14–24






version of the Munich-CIDI;
diagnoses made by using
DSM-IV criteria
The proportion of major depressive
episodes among those with an anxiety
disorder was low for those aged 14–17
years but increased at ages 18–24
years. Almost two thirds of cases with
anxiety disorder were comorbid with
major depression at follow-up
(OR 5 3.9 for generalized anxiety
disorder, OR 5 3.4 for panic disorder,
and OR 5 1.7 for specific phobia).
The number of anxiety disorders,
baseline impairment associated with
anxiety, the frequency of avoidance,
and the presence of panic-like attacks
all increased the risk of secondary






776 young people (aged





Used DISC to assess DSM-III
criteria from parents and children
at times 1 and 2; at time 3, DISC
used with the children only
Major depression at time 2 predicted
generalized anxiety disorder at time 3.
Overanxious disorder predicted major
depression at time 3. Conduct disorder
at time 1 was related to major depression
at time 3 (OR 5 2.54 (95% CI:
1.42, 7.68)). Conduct disorder at time
2 was related to major depression at







13.7 years at the first





Substance use disorders and
conduct disorder assessed with
DISC-I; instrument administered
to both the child and a parent;
DSM-III-R diagnoses made
Adolescents with conduct disorder had
2.59 times the hazard of initiating
marijuana use over the study period
in comparison to adolescents without
conduct disorder. Conduct disorder in
early adolescence was independently
associated with significantly elevated
mean symptoms of alcohol abuse/
dependency and marijuana use








































children who began 1st
grade in Woodlawn,
Chicago, in 1966–1967










measured by using the modified
version of CIDI based on
DSM-III-R criteria; major
depressive disorder measured
with CIDI; antisocial behavior
operationalized as ratings from
1st-grade teachers as
aggressive or shy and aggressive
Those who had been rated as aggressive
(OR 5 2.10) or as both shy and
aggressive (OR 5 1.93) in the 1st
grade were more likely to be current
smokers/early adopters than
nonsmokers. Those who had
comorbidity of major depressive
disorder and drug problems
(OR 5 4.70) were more likely to be
current smokers/early adopters than
nonsmokers compared with those






461 men from the Dunedin,
New Zealand, Multidisciplinary
Health and Development Study
8 years, at ages
18, 21, and
26 years
Alcohol abuse and marijuana
abuse assessed by symptoms
from the DIS*; antisocial




problems; DSM-IV criteria used
for these measures
Substance abuse exerts both proximal and
distal effects on desistance of antisocial
behavior over young adulthood. Men with
greater substance abuse at the end of
adolescence showed greater antisocial
behavior across young adulthood. Periods
in which men reported greater symptoms








289 families of male twins
and 337 families of female
twins, first assessed when
the twins were approximately
17 years of age in Minnesota
3 years Conduct disorder measured from
an adapted version of the
Structured Clinical Interview for
DSM-III-R Personality Disorders;
substance dependence
symptoms assessed by using
adolescents’ reports on a
modified version of the
Substance Abuse Module of
CIDI; DSM-III-R criteria used
Youths with late-onset antisocial
behavior had higher rates of substance
dependence than controls for all three
classes of substances. The late-onset
group also had more nicotine and
cannabis dependence than those with
desisting behavior. Youths with
persisting antisocial behavior had
more nicotine, alcohol, and cannabis
dependence than youths with no







506 boys in the Pittsburgh
Youth Study
6 years Drug use: assessed with the
16-item substance-use scale




Scale, the Youth Self-Report,
and the caretaker-completed
DISC-Parent Version; depressed
mood 5 number of symptoms
from the Recent Moods and
Feelings Questionnaire
Marijuana use was associated with higher
overall level of conduct disorder but did
not affect the rate of growth of conduct
disorder. No association was found
between oppositional defiant disorder
scores and marijuana use; oppositional
defiant disorder was a significant predictor
of level of alcohol use. Number of
symptoms of depression was positively











5th27th grade Conduct problems: youth
completed the 32-item Things
You Have Done survey at the
end of 5th grade, youth
completed the Self-Report
Delinquency Scale at the end of
7th grade; parents rated Child
Behavior Checklist, teachers
completed the externalizing scale
on the Teacher’s Report Form;
depressive symptomatology:
youth completed the Reynolds
Child Depression Scale at the
end of 5th and 7th grades and
parents completed a subscale
of the Child Behavior Checklist
This study did not find support for the
hypothesis that conduct problems
predict increases in depression in early
adolescence. Cases of comorbid
conduct problems and depressive
symptoms were significantly persistent
over time. A substantial portion of youth
in the conduct problems group in 5th
grade moved to the cooccurring group
by 7th grade. Serious depression or
conduct problems by 7th grade
occurred more frequently in comorbid



























































206 boys recruited through
4th-grade classes (depression
studied from ages 14–15
to 23–24 years) from Oregon
10 years Depressive symptoms: assessed
with the CES-D Scale; antisocial
behavior in late childhood:
antisocial construct from items
from the Teacher Child Behavior
Checklist, telephone interview
scores, peer nominations, home
observations, and interviewer
impression









Community sample of 496
female adolescents who
varied in age from 13 to 15
years at first assessment
from the metropolitan area
of the southwestern
United States
5 years Depressive symptoms: adapted
version of the K-SADS*;
antisocial behavior symptoms:
Externalizing Syndrome of the
Child Behavior Checklist;
substance abuse symptoms:
items adapted from Stice et al.
(76); DSM-IV criteria used for all
Initial depression level predicted
increases in substance abuse symptoms
and slower decreases in antisocial
behavior; initial levels of antisocial
symptoms predicted increases in
depression and substance abuse;
initial substance abuse level predicted







1,037 members of a
birth cohort in Dunedin,
New Zealand (baseline
beginning at age 11 years)
21 years: follow-
ups at ages 11,
13, 15, 18, 21,
26, 32 years
(N 5 972 at this
follow-up)
At ages 11–15 years, DISC used
to diagnose mental health
according to DSM-II; at ages
18–32 years, DIS used to
assess mental health by using
DSM-IV criteria
Adult anxiety cases were also more
likely to have experienced juvenile
depression relative to those without
adult anxiety. Adults with social phobia,
agoraphobia, and posttraumatic stress
disorder were more likely to have
experienced externalizing spectrum
disorders than those without these
disorders: adults with posttraumatic
stress disorder were likely to have
met diagnostic criteria for conduct






510 children aged 2–5
years at baseline from
Chicago, Illinois
5 years Externalizing and internalizing
behavior problems assessed
by the Child Behavior Checklist;
DSM-III-R diagnoses conducted
with the Diagnostic Interview for
Children and Adolescents
Single-diagnosis oppositional defiant
disorder at wave 1 was associated
with later comorbidity of oppositional
defiant disorder and mood disorders
and of comorbidity of oppositional
defiant disorder and an anxiety disorder.
There was moderate-to-high stability for
oppositional defiant disorder comorbid
with anxiety and low stability for








Pittsburgh Youth Study of
three samples of boys in
grades 1 (age 6.9 years),
4 (age 10.2 years), and 7
(age 13.4 years) (each
sample including 250 of
the most antisocial boys

















Child Behavior Checklist and the
DISC-Parent Version
administered to caretaker;
teachers given the Teacher
Report Form; boys assessed
with the National Youth Survey
40-item Self-Reported
Delinquency Scale and the
16-item Substance Use Scale
based on the National Youth
Survey; oppositional
defiant disorder: DSM-III-R
based on DISC-Parent Version
Persistent substance use in
preadolescence was predicted by
persistent delinquency and internalizing
problems, while persistent substance
use in adolescence was predicted by
persistent delinquency only. Comorbid
persistent substance use and
delinquency were predicted by
oppositional defiant disorder in
middle childhood and by persistent










































from high schools in
western Oregon aged
14–18 years
Mean 5 13.8 months Adolescents interviewed with a
version of K-SADS that combined
features of the epidemiologic
version (K-SADS-E) to derive
diagnoses based on DSM-II-R
criteria; alcohol use: four
symptoms for alcohol use and




Of adolescents with alcohol abuse/
dependence, 20% had an internalizing
disorder, 35% had an externalizing
disorder, and 45% had both internalizing
and externalizing disorders. 87.5% of
the time, anxiety disorders preceded
alcohol disorders, and, 80.0% of the
time, disruptive behavior disorders
preceded alcohol disorders. Comorbidity
was associated with an earlier age at
onset of alcohol disorder; 16% of
adolescents with a current psychiatric
disorder moved into a more problematic
alcohol use group from time 1 to time
2 vs. 5.8% of adolescents with no













at ages 13.9, 20.4,
and 25.4 years
Depression: assessed with the
self-report Recent Moods and
Feelings Questionnaire (contains
items with DSM-III criteria);
anxiety/withdrawal: assessed
with a scale that combined the
child (youth self-report), teacher
(Teacher Report form), and
parent-report Child Behavior
Checklist; alcohol use disorders
(assessed with the DIS on two
occasions in early adulthood
(DSM-III-R diagnoses)
Early conduct disorder symptoms
predicted increased alcohol use
disorder symptoms and alcohol
dependence diagnosis by young
adulthood. Adolescent boys with high
levels of anxiety/withdrawal had lower
levels of alcohol use disorder symptoms
and were less likely to develop alcohol
dependence by young adulthood.
Increased depression in early
adolescence was associated with
higher alcohol use disorder symptoms
and alcohol abuse and dependence
diagnoses by young adulthood, but













until age 16 years)
CAPA used to assess
psychiatric symptoms
Significant comorbidity was found
among the behavioral disorders and
anxiety and depression; depression
was comorbid with conduct disorder
in girls but not boys; depression was
comorbid with substance use disorder
in boys but not girls; anxiety predicted
later substance use disorder, but
depression did not; in girls, but not
boys, anxiety predicted depression








961 members of an
unselected birth cohort
from Dunedin, New Zealand
Aged 18–21 years Mental disorders (in the prior
12 months) assessed by using
the DIS to generate diagnoses
according to DSM-III-R criteria
A two-factor model provided the best
fit to the data: major depressive disorder,
dysthymia, generalized anxiety disorder,
agoraphobia, social and simple phobia,
and obsessive compulsive disorder
were presumed to reflect internalizing
problems; conduct disorder and
marijuana and alcohol dependence
were presumed to reflect externalizing
problems. Subjects retained their
positions regarding the latent factors


































































Substance use, abuse, and
dependence, as well as mental
disorders, assessed with the
DIA-X/M-CIDI, according
to DSM-IV
Major depression was associated with a
higher risk of cannabis use and dependence:
(OR for cannabis use 5 2.2 (95% CI: 1.3, 3.7);
OR for cannabis dependence 5 2.4 (95% CI:
1.3, 4.5)). Hypomania and mania were
associated with incident cannabis use and
cannabis dependence (OR for cannabis
use 5 2.4 (95% CI: 1.0, 5.4); OR for cannabis
dependence 5 2.7 (95% CI: 1.1, 6.3)). Among
anxiety disorders, only panic-anxiety was
associated with cannabis use (OR 5 3.1 (95%
CI: 1.4, 6.8)). Conduct problems predicted







173 high- and low-risk
youths in New Haven,
Connecticut (identified on
the basis of parental
history of substance
abuse) aged 7–17 years
1988–1998 Child diagnoses based on
K-SADS and independent
ratings from DSM-III-R
obtained from a child and
adolescent psychiatrist; tobacco
assessed using K-SADS
Psychiatric disorders were significantly
associated with nicotine dependence:
the association between having a
psychiatric disorder and dependence
vs. lower levels of use were as follows:
OR for anxiety 5 4.5 (95% CI: 1.71,
11.94), OR for affective disorder 5 10.7
(95% CI: 3.79, 30.25), OR for conduct
disorder 5 5.0 (95% CI: 1.6, 15.73),
OR for oppositional defiant
disorder 5 5.8 (95% CI: 1.80,
18.43); in the low-risk population,
oppositional defiant disorder was the











9, 11, and 13 years
to age 16 years
CAPA used to assess
psychiatric symptoms
Disruptive behavior disorders and
depression were associated with a
higher rate and earlier onset of
substance use and abuse in both sexes,
but anxiety predicted later onset of
smoking. Onset of conduct disorder
and anxiety was well before the first
use of any substance. Substance use
and abuse of every type were more
common among girls with behavior
disorders; depressed boys, compared
with nondepressed boys, had








1,420 children aged 9, 11,






CAPA used in interviews;
substance use, abuse, and
dependence items used;
psychiatric disorders classified
by using DSM-IV criteria for
symptoms experienced in the
past 3 months
Conduct disorder, particularly at earlier
ages (14 and 15 years) was the
strongest psychiatric predictor of
transition from substance use to a
disorder (OR 5 2.0 (95% CI: 1.2, 3.6)).
Boys, but not girls, with a history of
depression were at increased risk of
substance use disorder; anxiety
increased the risk of substance use
disorder in girls at age 16 years.
* CIDI, Composite International Diagnostic Interview; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; OR, odds ratio; CI, confidence interval; DIA-X/M-CIDI;
Munich-Composite International Diagnostic Interview; CAPA, Child and Adolescent Psychiatric Assessment; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, Third Edition,
Revised; DISC, Diagnostic Interview Schedule for Children; IRR, incidence rate ratio; CES-D, Center for Epidemiological Studies Depression; DIS, Diagnostic Interview Schedule; K-SADS,


































symptoms at follow-up, but depression did not predict sub-
stance use disorders at follow-up (34).
Adults. Comorbidity between depression and sub-
stance use persists until adulthood: there is a two- to four-
fold higher risk of developing one disorder if the other has
occurred (37, 38). As has been detected in adolescence and
young adulthood, support also exists for the use of alcohol
and illegal substances as a way to manage depressive symp-
toms in adulthood (37, 39–41). Several studies also docu-
ment a reciprocal association between the two, as was the
case with anxiety (42, 43). Gilman and Abraham (42) fol-
lowed up participants from the Epidemiologic Catchment
Area Survey and found that, although the odds of alcohol
dependence increased in relation to baseline depressive
symptoms, the odds of major depression also increased in
response to the number of alcohol symptoms and a diagnosis
of alcohol dependence.
Anxiety and depression
High rates of comorbidity have been found between anx-
iety and depression. An important fraction of depression
cases also present symptoms of anxiety, to the point that
Krueger et al. (8) proposed that ‘‘pure’’ cases of depression
or anxiety would be unrepresentative of the entire spectrum
of these disorders. In a 40-year follow-up of levels of anx-
iety and depression, the probability of having anxiety for
those who already suffered from depression ranged from
0.54 to 0.98, while, for those who did not suffer from de-
pression, the probability ranged from 0.03 to 0.10 (44).
Anxiety and depression function in a cohesive manner and
have been classified as internalizing disorders, which are
stable over time (8, 45). The comorbidity of these disorders
has raised some controversy. While some argue that anxiety
and depression are distinct disorders with different etiologic
profiles and high levels of cooccurrence, others interpret the
overlap as indicative of similar psychopathologic processes
and shared risks or as different manifestations of the same
disease (26, 46).
Children and adolescents. Strong heterotypic conti-
nuity exists between depression and anxiety from childhood
to adulthood (2, 18, 26, 47–51). In the Great Smoky Moun-
tains study that followed a cohort of children aged 9–13
years for 5 years, anxiety predicted depression and vice
versa, even when controlling for current comorbidity (18).
A gender-specific analysis indicated, however, that the asso-
ciations independent of current comorbidity persisted
among girls only. Another study that followed those aged
9–18 years over 9 years found that overanxious disorder in
adolescence was associated with adult major depression,
while major depression in adolescence predicted general-
ized anxiety in adulthood (50). These associations were in-
dependent of gender.
The degree of comorbidity between depression and anx-
iety may vary as a function of age. Wittchen et al. (26)
followed 3,021 respondents aged 14–24 years at baseline
over 4 years and found that, although only 9 percent of those
with an anxiety disorder at ages 14–17 years also had major
depressive episodes, the proportion was considerably higher
among those aged 18–24 years. Moreover, depression in-
creased considerably among those with anxiety disorder at
final follow-up: almost two thirds of cases were comorbid
with major depression. The variation in comorbidity by age
might be a function of age at onset of the two disorders;
whereas anxiety disorders tend to start in childhood and
early adolescence, depressive disorders increase in late ad-
olescence and continue to rise in those aged 20 years or
older (2, 26, 52).
The frequency and type of comorbidity differ by disorder.
Wittchen et al. (26) found that the odds ratio for presenting
major depression at follow-up ranged from 1.7 for specific
phobia to 3.4 for panic disorder and 3.9 for generalized
anxiety disorder. Pine et al. (50) also found that major
depression predicted generalized anxiety disorder but not
simple or social phobia.
Comorbidity is related to symptom severity, degree of
impairment, course, and outcome. Wittchen et al. (26)
found, in a study of 3,021 respondents aged 14–24 years
at first interview followed over 4–5 years, that the number
of anxiety disorders present, persistence of anxious avoid-
ance behavior, and degree of psychosocial impairment were
the characteristics most strongly associated with develop-
ment of secondary depression. Repetto et al. (51) confirmed,
in a more restricted study of African-American adolescents
at risk of school dropout, that adolescents who presented
consistently high levels of depressive symptoms were more
likely to present a higher number of anxiety symptoms.
Adults. Most studies have identified anxiety as a pri-
mary disorder that precedes secondary depression, perhaps
related to the difference in ages at onset as well as to the
higher degree of stability of anxiety. A critical review of
longitudinal studies of representative samples, however, in-
dicates that this question remains unsettled and may depend
on life stage examined, length of study follow-up, and type
of anxiety disorder studied. A follow-up of a representative
population sample over 10 years from early adolescence to
young adulthood found that social anxiety disorder was
temporally primary relative to depression in most of the
cases and that the risk of subsequent depression was twofold
for individuals with social anxiety disorder in comparison to
those without social anxiety disorder (53). However, a study
that followed up a birth cohort until age 32 years (54) found
that major depression preceded generalized anxiety disorder
almost as often as generalized anxiety disorder preceded
major depression. Two studies in older adulthood found that
anxiety preceded depression within short time intervals.
A study of older Swedish twins found that over two 3-year
intervals, anxiety symptoms led to depressive symptoms,
while the opposite did not occur (46). The same phenome-
non was reported among the elderly for depression and gen-
eralized anxiety disorder: a follow-up of a sample of
community-living elderly over 3 years found that general-
ized anxiety disorder either remitted or progressed into de-
pression or mixed anxiety/depression, whereas subjects with
depression or depression/generalized anxiety disorder were
unlikely to develop noncomorbid generalized anxiety disor-
der at follow-up (12).
Comorbid disorders may be more stable than ‘‘pure’’
cases of disease. A study that followed adults aged 19–20
years at baseline over 15 years found that substantial
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TABLE 2. Population studies on comorbid patterns between substance abuse, anxiety, depression and conduct disorder among adults










age at onset data
Diagnoses based on DSM-III-R*
from the CIDI*
The association between major depression and alcohol or
drug dependence was stronger than that for alcohol or
drug abuse. Men were more likely than women to
report major depression temporally secondary to any
other disorder; of those who had ever experienced a
mood disorder, 46% of males and 57% of females
had a history of anxiety disorders, and 43% of males
and 15% of females had a substance use disorder; in










At years 1, 4,
and 7
Anxiety disorders (generalized
anxiety disorder, social phobia,
agoraphobia with panic attacks,
panic attacks in the absence of
agoraphobia): assessed with DIS*
version III-R to use criteria from
DSM-III; alcohol abuse/dependence:
used DIS and DSM-III
Strong evidence was found for reciprocal causal
influences between anxiety disorders and alcohol
dependence; having an anxiety disorder at years
1 or 4 quadrupled the risk for new onset of alcohol









4 years Polydrug problems assessed with
items based on DSM-IV*
criteria for drug abuse and
dependence; anxiety (included
in the agitation measure)
measured by three items on
a 5-point Likert rating scale,
taken from the Hopkins
Symptom Checklist
Early dysphoria directly increased agitation as an adult.
Polydrug problems in young adulthood increased
anxiety in adulthood. Social conformity accounted
fully for the relation between polydrug problems and
agitation. Marijuana problems in early adulthood
increased later suicidal ideation. Early cocaine
problems increased later hostility. Dysphoria in
young adulthood increased alcohol problems but













Retrospective Drinking outcomes measured
with Semi-Structured
Assessment for the Genetics
of Alcoholism (onset defined
as age at which full DSM-IV
criteria were met); lifetime
diagnoses for DSM-IV mood,
anxiety, and conduct-related
disorders also obtained
Nicotine dependence (HR* 5 3.91 (95% CI*: 2.48, 6.17))
and generalized anxiety disorder (HR 5 3.45 (95% CI:
2.08, 5.72)) were robust predictors of progression from
first drink to alcohol dependence; conduct disorder
(HR 5 1.75 (95% CI: 1.10, 2.77)) and cannabis abuse
(HR 5 1.88 (95% CI: 1.22, 2.90)) were also associated

















When age/gender/comorbid depressive disorder were
controlled for, baseline nonusers with at least one
social fear but no social phobia diagnosis showed
elevated odds for an occurrence of nicotine
dependence in the follow-up period (OR* 5 3.85
(95% CI: 1.34, 11.00)). All baseline, nondependent,
regular smokers with social fears but not social
phobia also showed higher odds for nicotine










15 years DIS assessed symptoms of
DSM-III disorders at baseline
and DSM-III-R symptoms at
baseline; outcomes measured
by using the 20-item version
of Goldberg’s General Health
Questionnaire to assess
general distress, DIS for
psychiatric disorders, and
DIS for symptoms of substance
abuse/dependence
Anxiety/depression did not predispose individuals to















































Depression measured with DIS
by using DSM-III criteria; alcohol
dependence measured as 1)
lifetime and 2) new onset;
DSM-III criteria used at
baseline and 1 year follow-up,
DSM-III-R criteria
used at 12.6-year follow-up
Depressive syndrome was associated with lifetime
prevalence of alcohol dependence: for women,
OR 5 1.89 (95% CI: 1.16, 3.06), while, for men,
OR 5 1.83 (95% CI: 1.14, 2.93). Depressive syndrome
was not associated with onset of alcohol dependence.
Having a current or prior anxiety disorder increased
the odds of alcohol dependence among women:








ranging in age from
18 to 65 years,
who did not report
heavy alcohol use
at baseline
1 year Center for Epidemiologic Studies
Depression Scale heavy alcohol
use measured as five or more
drinks at least once in the past
month; depression measured
with DIS by using DSM-III criteria
The estimated risk of heavy alcohol use for women with
major depression, depressive syndrome, and/or
dysthymia was 2.22 greater than the risk for women
without such a history (95% CI: 1.00, 4.92). The
adjusted relative risk of heavy alcohol use
associated with an incremental number of
lifetime-experienced depressive symptoms












age, 43 years (range,









1 year Both alcohol dependence and
major depression measured
with the DIS by using DSM-III
criteria; administered
by nonclinician interviewers
The odds of alcohol dependence associated with
number of baseline depressive symptoms were,
for females, 1–3 symptoms, OR 5 2.75 (95% CI:
1.52, 5.00), 4–6 symptoms, OR 5 3.52 (95%
CI: 1.86, 6.66), 7 symptoms, OR 5 7.88 (95%
CI: 2.86, 21.70); for males, 1–3 symptoms, OR 5 1.50
(95% CI: 1.08, 2.08). The odds of depression associated
with 1–3, 4–6, and 7 alcoholic symptoms,
respectively, were, for females, OR 5 1.66 (95% CI:
1.05, 2.64), OR 5 3.98 (95% CI: 2.37, 6.69), and
OR 5 4.32 (95% CI: 1.92, 9.75); for males, OR 5 1.19
(95% CI: 0.76, 1.88) OR 5 2.49 (95% CI: 1.26, 4.92),
and OR 5 2.12 (95% CI: 0.90, 5.00). The odds of
major depression corresponding to a DSM-III alcohol
dependence diagnosis were 3.52, 95% CI: 2.16, 5.72























based on the modified SCID*
Generalized anxiety disorder and major depressive
disorder had the highest same-year onsets (about
41%); panic disorder tends to occur after major
depressive disorder in females but before major
depressive disorder in males; the majority of
phobias precede major depressive disorder in both
genders. Onset of alcohol dependence precedes
that of major depressive disorder in about one third
of cases; for psychoactive substance use disorder,
onset for females was about evenly divided between
those occurring before (44%) and after (49%) major
depressive disorder, significantly more males
(54%) reported onset before that of major depressive
disorder. Generalized anxiety disorder and panic
disorder cases had the highest risk of developing
concurrent major depressive disorder, with same-year-


































































a mean age of 37.0
years in Virginia
Two measurements:
waves 1 and 4 for
female-to-female
twin pairs and waves






assessed by using adapted
versions of standard structured
interviews (not specified)
Risk of developing alcohol dependence associated with
lifetime or concurrent major depression was higher for
males than for females. Risk of alcohol dependence in
year 1 associated with major depression onset in the
prior year was higher than that associated with
lifetime major depression: twofold for males and
fourfold for females. Among females, the risk of
alcohol dependence associated with prior major
depression was higher than that associated with
concurrent major depression (HR 5 5.1 vs. HR 5
3.1). Lifetime alcohol dependence predicted
increasing HR of major depression for both
genders, and the effect was stronger for females.
Concurrent alcohol dependence had the highest
effects on major depression risk. However,
compared with lifetime alcohol dependence,












CIDI used Of respondents who developed an incident disorder,
16.1% developed comorbid disorders; anxiety-
comorbid mood disorder was the most frequent
incident comorbid disorder among females, and
both anxiety-comorbid and substance use-comorbid




















according to DSM-IV assessed
with the computer-assisted
DIA-X/M-CIDI
Male former or current daily smokers had higher odds
ratios of affective and anxiety disorders: compared
with male never smokers, male current daily
smokers had 4.5 higher odds of having an
anxiety disorder. Having 1–2 nicotine dependence
symptoms was associated with higher odds of
affective (OR 5 1.7 (95% CI: 1.2, 2.4)) and anxiety
(OR 5 1.6 (95% CI: 1.2, 2.2)) disorders; having 3
symptoms was associated with 3.6 times higher
odds of affective disorders (95% CI: 2.6, 5.0) and












10 years Individuals assessed with
the DIA-X/M-CIDI
Social anxiety disorder was consistently associated with
subsequent depression, independent of age at onset of






from a list of all





3.5 years DIS used, following DSM-III-R
criteria
Higher lifetime prevalence of major depressive disorder
in females vs. males was primarily for major
depressive disorder comorbid with anxiety; prior
history of an anxiety disorder was associated with
increased risk of major depressive disorder in males
and females. Prior anxiety disorder accounted for
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3.5 years DIS used, following DSM-III-R
criteria
Prior anxiety was associated with a higher risk of major
depressive disorder in both sexes. Women were not
more vulnerable than men to depression because
of an anxiety disorder. Substance use disorder does
not play the comparable role in men that anxiety










CIDI used 15.2% of pure mood, 10.5% of anxiety, and 6.8% of
substance use disorder cases became comorbid; half
the transitions from pure substance use disorders were






with an average age




1 year Social anxiety measured by using
the Social Phobia and Anxiety
Inventory; depressive symptoms
measured by using the Beck
Depression Inventory
22% of the total effect of time 1 social anxiety on time
2 depressive symptoms was accounted for by
avoidance of expressing emotions. Individuals with
social anxiety disorder may develop depressive
symptoms to the extent that they withhold strong








aged 19 and 20
years representative
of the canton of
Zurich, Switzerland
15 years The Structured Diagnostic
Interview for Psychopathologic
and Somatic Syndromes used
to make diagnoses according
to DSM-III and DSM-III-R
criteria for most major
categories
Concurrent comorbidity between anxiety and depression
was highly stable across the 15 years of the study
(OR range: 3.0–6.0); subjects with anxiety only had a
moderate probability of developing depression only
(OR range: 1.5–7.8), whereas those with depression
only did not develop anxiety only (OR range: 0.3–1.8);
substantial transitions from pure anxiety or pure
depression to comorbid depression/anxiety (OR range:
1.5–10.0); women were more likely than men to






1,037 members of a
birth cohort (972 were




at ages 11, 13,
15, 18, 21, 26,
and 32 years)
At ages 11, 13, and 15 years,
diagnoses with DSM-III criteria
made with the DISC*-Child
Version and, at older ages,
with the DIS (at ages 18 and
21 years, DSM-III-R; at ages
26 and 32 years, DSM-IV);
both generalized anxiety
disorder and major depressive
disorder diagnosed
Cumulative prevalence of adult comorbid major
depressive disorder 1 generalized anxiety disorder
was 12% in the cohort; sequential and cumulative
comorbidity was balanced: 37% of cases of
depression were preceded by anxiety disorders,
but 63% were not; the two disorders had strong
cumulative lifetime comorbidity from ages 11 to
32 years (OR 5 5.3 (95% CI: 3.9, 7.2)); of lifetime
major depressive disorder cases, 48% had lifetime
anxiety disorder; of lifetime anxiety cases, 72% had






with an average age





with the Center for
Epidemiologic Studies
Depression Scale; anxiety
assessed with the State
Anxiety subscale of the
State-Trait Personality Inventory
A two-factor model with latent depression and anxiety
factors provided the best fit to the data; the two factors
were highly correlated (0.84). Between 1987–1990 and
1990–1993, the parameters for the paths linking anxiety
to subsequent depression were significant, whereas the
paths linking depression to subsequent anxiety were











15 years DIS and subsequently its newer
form, CIDI, used to find cases
of depression and anxiety; DIS
and CIDI used to generate
DSM-III and then DSM-III-R
diagnoses
Subjects with two or more episodes of major depression
had higher rates of meeting ‘‘major anxiety’’ and ‘‘all
anxiety’’ status than those with one episode. Those
with one episode had higher rates than subjects in
the ‘‘no depression’’ group. Mean age at onset of
simple phobia was significantly younger among those
who had multiple episodes of depression. One of the
best predictors to distinguish between ‘‘no depression’’





























































Study of the Elderly
3 years Dutch translation of the Mini-Mental
State Examination, the Geriatric
Mental State Examination, the
Activities of Daily Living scale, the
Instrumental Activities of Daily
Living scale, and the Cambridge
Mental Disorders of the Elderly
Examination interview used;
diagnoses of depression, organic
‘‘caseness,’’ and generalized
anxiety reached by use of the
Geriatric Mental State–AGECAT
system
Depression and generalized anxiety disorder together had
a significantly worse prognosis (27% remission) than the
‘‘pure’’ categories: 4 of 199 subjects with depression
developed generalized anxiety disorder (pure
generalized anxiety disorder), but 27 (13.6%)
developed pure depression/generalized anxiety
disorder; subjects with pure depression/generalized
anxiety disorder at baseline were more likely to
















Mental disorders assessed by
using CIDI to generate
diagnoses according
to DSM-IV criteria and the
ICD-10* diagnostic system
Oppositional defiant disorder is associated with
substantial risk of secondary mood, anxiety, impulse-
control, and substance use disorders; 92.4% of
respondents with lifetime oppositional defiant disorder
met criteria for at least one other lifetime disorder;
oppositional defiant disorder was significantly comorbid
with agoraphobia without panic disorder (OR 5 2.1)
and conduct disorder (OR 5 12.6). The ORs for
impulse control disorders were 4.0–12.6, and the















Index (GSI), and one





20 years Alcohol abuse and dependence
classified according to DSM-IV
criteria; major depressive
episodes defined by DSM-III
criteria in the first two interviews
(1979 and 1981) and DSM-III-R
criteria in the last four interviews
(1986, 1988, 1993, and 1999)
Major depressive episodes were associated with alcohol
dependence but not with alcohol abuse: for men,
OR 5 3.8 (95% CI: 2.0, 7.1); for women, OR 5 5.2









30 years Conduct problems in school:
teachers rating students on a
3-point scale at grades 6 and 9;
conduct problems in the
community: defined as children




admissions to psychiatric wards
Males identified with conduct problems in childhood
were more likely than the no-conduct-problems group
to develop substance abuse in adulthood; females
identified with conduct problems in childhood were at
greater risk than no-conduct-problems females for crime
and for mental disorders in adulthood; a diagnosis of
substance abuse accounted for most of the mental














Axis I disorders assessed with
DISC-I, the nonpatient version
of the structured clinical
interview for DSM-IV
(SCID-IV-NP) at age 33 years;
assessment of personality
disorders with items from the
Personality Diagnostic
Questionnaire, the Structured
Clinical Interview for Personality
Disorders (SCID-II) and DISC-I
Individuals with a DSM-IV cluster A (paranoid, schizoid,
or schizotypal) or cluster C (avoidant, dependent,
obsessive-compulsive) panic disorder by mean age 22
years were at elevated risk of recurrent or chronic
unipolar depression; antisocial, borderline, dependent,
depressive, histrionic, and schizotypal panic disorder
traits, identified between the ages of 14 and 22 years,
were significantly associated with risk of dysthymic


































transitions occurred from anxiety and depression alone to
comorbidity; an average of 21 percent of those with depres-
sion alone and 24 percent of those with anxiety alone de-
veloped comorbid anxiety and depression at baseline, and,
once comorbidity developed, the recurrence of either disor-
der alone was much lower (55).
Specificity also exists in the degree of comorbidity be-
tween different types of anxiety disorders and depression.
Generalized anxiety disorder has been identified as the type
of anxiety disorder most closely connected with major de-
pression (54). Wilhelm et al. (56) followed a cohort of sub-
jects involved in teacher training in 1978–1993 and found
a stronger association between number of depressive epi-
sodes and panic disorder, generalized anxiety disorder, and
agoraphobia than between number of depressive episodes
and either simple or social phobia. Gregory et al. (49) fol-
lowed a representative birth cohort from ages 11 to 32 years
and found that adult anxiety cases were more likely to have
experienced juvenile depression than those without adult
anxiety, except for specific phobia and panic disorder cases.
The specific nature of the associations between depression
and anxiety may depend on certain interpersonal features of
anxiety disorders. Two studies have found, for example, that
behavioral inhibition (53) and avoidance of expressing emo-
tions (57), rather than lack of assertion or interpersonal de-
pendency, explained part of the transition from social
anxiety disorder to depression. Grant et al. (57) hypothesized
that inhibition of strong emotions to significant others as
a strategy to maintain associations may lead to a loss of self,
which may increase depressive symptoms.
Conduct disorder and substance use
Conduct disorder has been defined in the Diagnostic and
Statistical Manual of Mental Disorders: DSM-IVas a perva-
sive pattern of aggressive and deceptive behavior that begins
in adolescence (58). Conduct disorder and substance use
have been classified under the same latent construct of ex-
ternalizing disorders (8). Measelle et al. (36) found, for ex-
ample, that an externalizing factor accounted for 79 percent
and 95 percent of the baseline levels of antisocial behavior
and substance abuse, respectively. Both disorders tend to
increase through late adolescence and peak in young adult-
hood, and they are more prevalent among males (59). Sev-
eral studies have proposed that a major fraction of the
association can be attributed to common genetic factors (45).
Children and adolescents. Most studies on conduct
disorder and substance use concern adolescence and young
adulthood. Similar to anxiety and depression, the direction-
ality of the link between these conditions and conduct seems
to vary across studies (18, 30, 49, 60–62). Cohen et al. (60)
followed up 749 adolescents from ages 13 to 24 years and
found that participants with conduct disorder in early ado-
lescence experienced significantly elevated rates of alcohol
abuse/dependency and marijuana use disorder between early
adolescence and young adulthood. Kratzer and Hodgins
(63) found a similar phenomenon when they followed an
unselected birth cohort from pregnancy to 30 years of age:
childhood conduct problems were associated with a higher
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beyond examining the influence of conduct disorder on lev-
els of substance abuse and investigated its influence on both
mean levels of use and change in use over time. Although
conduct disorder was associated with higher overall levels
of alcohol and marijuana use throughout the study period, it
predicted change in levels of alcohol use only. Participants
with higher levels of conduct disorder began adolescence
with higher levels of alcohol use, but their level of alcohol
use grew slower than that among participants who had lower
initial levels of conduct disorder—possibly because of re-
gression to the mean.
Some of the most promising studies on comorbidity have
investigated the impact that conduct disorder and substance
abuse have on the developmental patterns of the comorbid
disorder. Conduct disorder, for example, has been found to
play an important role in the shift from substance use to
substance use disorders (30, 65). The Great Smoky Mountains
study found that conduct disorder, particularly at earlier
ages (14 and 15 years), was the strongest psychiatric
predictor of the transition from substance use to a disorder
(62). Substance abuse can play a role in crime desistance in
young adulthood (45, 66). Hussong et al. (66) found that
substance abuse may exert both proximal and distal effects
on antisocial desistance over young adulthood: 1) substance
abuse early in young adulthood can slow an individual’s
pattern of criminal desistance relative to the lifetime pattern
of criminality; and 2) substance abuse can result in ‘‘time-
specific’’ elevations in antisocial behavior relative to an in-
dividual’s own antisocial trajectory. A community sample of
female adolescents aged 13–15 years found that, although
initial levels of antisocial behavior predicted increases in
substance abuse, substance abuse also predicted slower de-
celeration in antisocial behavior (36); a study of female and
male twin pairs reported that youths with late-onset and
persisting antisocial behavior had higher rates of substance
use than youths in groups without a history of antisocial
behavior or a pattern of antisocial desistance (67).
Adults. We found one study that examined the influ-
ence of conduct disorder on substance abuse but used retro-
spective reports of age at onset for comorbid disorders. The
National Comorbidity Survey Replication indicated that
lifetime conduct disorder was associated with 5.9 times
higher odds for substance use disorders (58). Conduct disor-
der was more likely to occur before substance use disorders
88.5 percent of the time. Although both active and remitted
conduct disorder were significant predictors of substance use
disorders, the risk of substance use disorders was signifi-
cantly higher for those with active conduct disorder. The
persistent effect of remitted conduct disorder may indicate
that conduct disorder is a risk marker for unmeasured com-
mon causes of substance use disorders or that active conduct
disorder has long-lasting consequences that persist even af-
ter the disorder has remitted. The higher risk associated with
active conduct disorder may also, however, point to a causal
role that conduct disorder plays in related disorders.
Conduct disorder and anxiety and depressive disorders
The limited number of studies identified that addressed
the connections between conduct disorder and either depres-
sion or anxiety led us to group the review of these disorders
into one section. Factor analyses of internalizing disorders,
notably anxiety and depression, and externalizing disorders,
of which conduct disorder constitutes an important fraction,
have identified distinct developmental patterns for these two
groups of disorders but have also detected a correlation
across time between the two types of disorders (8, 45). Little
is understood about the mechanisms that may connect con-
duct disorder with mood disorders. Conduct disorder may
disrupt interpersonal functioning, contributing to greater
conflict with parents and peers and greater social rejection
and academic failure, which may generate a sense of re-
peated failure and feelings of anxiety or depression (68).
At the same time, depression and anxiety may impede social
development and generate interpersonal conflict, which may
contribute to the onset of conduct problems. Common etio-
logic factors may also underlie both types of disorders (69).
The developmental course of conduct disorder tends to be
intertwined with internalizing problems, particularly de-
pression (36). For example, a study involving a community
sample of female adolescents followed from early to late
adolescence found that initial depressive and antisocial be-
havior symptoms predicted future increases in the other:
while initial levels of antisocial symptoms predicted in-
creases in depressive symptoms, initial levels of depression
predicted a slower deceleration in antisocial problems (36).
Early antisocial problems have also been found to predict
depressive symptoms in adulthood (69–71). Kim et al. (70)
found that, among young men followed from early adoles-
cence to young adulthood, early antisocial behavior was
associated with depressive symptoms in adulthood; Silberg
et al. (71) detected a correlation between early conduct
problems and later depression among adolescent female
twin pairs. The link may be explained by a failure model,
whereby early developmental failures associated with
antisocial behavior increase vulnerability to depressive
symptoms (36).
Some evidence also exists of a link between conduct
disorder and specific types of anxiety (49, 58, 61, 72).
A birth cohort of a representative sample followed from
ages 11 to 32 years showed an association between a juvenile
history of conduct disorder and posttraumatic stress disorder
at age 32 years (49). A longitudinal study of a population
sample assessed from ages 14 to 33 years also found that the
presence of antisocial personality disorder traits at ages 14–22
years was associated with a higher risk of anxiety disorders
by age 33 years, most particularly for agoraphobia (72).
The National Comorbidity Survey Replication found mixed
evidence about the temporal order between conduct disorder
and anxiety: conduct disorder occurred after specific and
social phobia but prior to all other types of anxiety disorders
(58). The findings from the National Comorbidity Survey
Replication require replication within a longitudinal study
because they are based on retrospective reports of age at onset.
Putting it all together: internalizing and externalizing
disorders as predictors of substance abuse
Most studies on comorbidity assess the interaction be-
tween pairs of disorders concurrently and over time, but
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they fail to determine how clusters of disorders may pro-
mote onset of psychopathology. One exception has been the
area of youth risk behaviors; selected studies have investi-
gated the relative influence of externalizing and internaliz-
ing disorders on the prevalence of substance abuse or
conduct disorder. Adolescence has long been considered
the stage at which risk behaviors such as delinquency and
substance use are initiated and when disorders such as sub-
stance abuse become consolidated (36, 73). It is a time when
multiproblem youth emerge, characterized by persistent
substance use, persistent delinquency, and/or persistent
internalizing problems (74). This peak in comorbidity
has motivated studies of the intersections between mul-
tiple forms of psychopathology in adolescence and young
adulthood.
Loeber et al. (74), for example, used longitudinal data
from three samples of the Pittsburgh Youth Study to exam-
ine the cooccurrence of persistent substance use with de-
linquent and persistent internalizing problems in boys aged
7–18 years. The joint occurrence of mood dysregulation, in
the form of internalizing problems, and behavioral dysregu-
lation, in the form of delinquency, emerged in preadoles-
cence and played a significant role in the persistence of
substance use. During adolescence, however, only persistent
delinquency predicted persistent substance use. Another
publication using the Pittsburgh Youth Study expanded this
investigation by examining how the cooccurrence of con-
duct disorder and depressive symptoms identified high-risk
youth (25). The authors found that higher levels of depres-
sion led to the development of alcohol use disorder symp-
toms but among only those subjects who had high levels of
early conduct disorder symptoms. The interaction between
depression and conduct disorder may indicate a need to
manage negative affective states without a high regard for
social norms, or it may indicate a subgroup of individuals at
particularly high risk of developing a severe form of sub-
stance use.
Summary
Prospective population studies that investigate the se-
quential links between comorbid disorders remain scarce.
The bulk of prospective studies assess the influence of the
prevalence of one disorder on the future prevalence of the
comorbid disorder. Few studies actually move beyond this
topic to investigate the influence that comorbidity may have
on changes in the state of psychopathology, that is, in shifts
from persistence to desistance, or from substance use to
abuse, or from disorder-free status to onset. Such informa-
tion would provide initial evidence of the specific mecha-
nisms by which disorders influence each other. Moreover,
differences in the duration of study follow-up, choice of age
groups, and selections of measurement instruments and di-
agnostic criteria make comparability across studies more
difficult.
Despite these limitations, several points emerge from our
review of population-based studies of comorbid disorders.
The concurrent and sequential links among conduct disor-
der, substance use/abuse, anxiety, and depression are neither
random nor a result of bias from help-seeking clinical sam-
ples. The nature of comorbidity is specific to the type of
disorder under study: evidence exists for a reciprocal rela-
tion between substance use and depression, anxiety, and
conduct disorder, while the bulk of studies on depression
and anxiety indicate that anxiety may precede onset of de-
pression. The studies that address comorbidity of conduct
disorder with anxiety and depression indicate that conduct
disorder may precede these mood disorders, but the paucity
of studies that test a reciprocal association impede us from
making conclusive statements.
The mechanisms that connect disorders remain in ques-
tion. Three hypotheses link comorbid disorders: 1) the as-
sociation may be indirectly causal, so that a primary
disorder may exert neurophysiologic, individual, or social
changes that increase vulnerability to the secondary disor-
der; 2) disorders may be directly linked, so a primary dis-
order may, for example, exert neurophysiologic changes that
contribute to onset of the secondary disorder; or 3) a set of
common risk factors, such as common genes or the experi-
ence of childhood trauma, may explain the connection be-
tween two disorders. However, these hypotheses are difficult
to distinguish from one another. For example, a social factor
such as affiliation with deviant peers could predispose ado-
lescents to both substance use disorder and conduct disorder
(hypothesis 3), but conduct disorder could also lead to as-
sociation with deviant peers, which would contribute to sub-
stance use disorder (hypothesis 1). A review of the risk
factors associated with the initiation and maintenance of
comorbid conditions can help illuminate the mechanisms
that underlie comorbidity in psychopathology.
CONCLUSIONS
Understanding patterns of comorbidity is essential in or-
der to evaluate psychiatric nosology and fully understand
the developmental trajectories of key forms of psychopa-
thology. To date, a number of studies have shown that anx-
iety, depression, substance abuse, and conduct disorder
cluster in individuals across the life course. This critical
review is one of the first focused on population-based, lon-
gitudinal studies of comorbidity between these four key
disorders.
The four psychiatric disorders we reviewed have been
classified under two latent constructs: externalizing and in-
ternalizing disorders. Although factor analyses indicate
a higher correlation between disorders within each con-
struct, clustering also exists between externalizing and in-
ternalizing disorders. Approaching first the issue of
internalizing disorders, anxiety and depression function
jointly from childhood to adulthood. Comorbidity seems
to be a function of age; it increases from late adolescence
onward, possibly because of the later age at onset of de-
pression relative to anxiety. Comorbidity also depends on
the type of anxiety disorder concerned: several studies
found a higher clustering between major depressive disorder
and generalized anxiety disorder, for example, than with
other anxiety disorders. In terms of externalizing disorders,
conduct disorder and substance abuse show a strong recip-
rocal link, particularly in adolescence and young adulthood.
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Conduct disorder and substance abuse not only influence the
onset and prevalence of the other but also influence the shift
between developmental stages of the other disorder, that
is, in shifts from substance use to a substance use disorder,
or in the likelihood of moving from conduct disorder to
desistance.
Studies have documented a link between disorders across
the internalizing/externalizing divide. Studies indicate that
the relation between substance abuse and anxiety or depres-
sion is reciprocal: substance abuse alone or depression/
anxiety alone predicts onset of the other disorder. The im-
pact of anxiety on substance abuse remains in question:
anxiety disorders have been associated with both a higher
and a lower likelihood of substance use disorders. The di-
rection of the association may depend on the type of anxiety
disorder and substance in question. Research has also ad-
dressed the question of clustering between conduct disorder
and anxiety/depression, although research is less developed
in this area. Depression and conduct disorder play a role in
shaping the developmental trajectory of the other. Initial
levels of depression have been associated with a slower rate
of desistance from conduct disorder, while conduct disorder
predicted increases in depressive symptoms from adoles-
cence to adulthood. The links between anxiety and conduct
disorder are less understood. The few existing studies focus
on adolescence and young adulthood and have indicated that
initial levels of conduct disorder were associated with
higher levels of anxiety.
Existing research on comorbidity has a number of
strengths. Prospective studies linking the presence of one
disorder to onset of the other, as well as examining the in-
fluence that a disorder may have on developmental shifts in
comorbids, are growing, and they offer promise in enabling
us to understand the specific ways in which comorbid dis-
orders are linked over the life course. Moreover, research is
shifting from a focus on a pair of disorders to a more holistic
approach that analyzes how clusters of disorders interact
with each other. We think this line of investigation will be
key in understanding the complexity of comorbid relations
and in estimating the health burden that results from multi-
ple comorbidities.
At the same time, the epidemiologic literature falls short
in its consideration of key issues within comorbidity re-
search. First, although early research in this area is promis-
ing, a need exists for study designs that make it possible to
test the timing and specific nature of comorbid relations—
that is, shifting from merely investigating whether disorders
are ‘‘associated’’ with each other to understanding the ways
that disorders deflect a comorbid pair from specific stages in
its normative trajectory. This process involves studying the
influence of disorders in promoting qualitative shifts in the
comorbid disorder, from alcohol use initiation to abuse to
dependence, for example. It also implies accounting for the
spectrum of relevant comorbid disorders within the same
study to control for spurious associations and understand
how the presence of a third disorder may influence the
causal link between comorbid pairs.
Second, our understanding is limited in terms of the spe-
cific comorbid patterns between subtypes of disorders.
Although we recognize that specific types of anxiety disorders,
for example, may show different comorbidity patterns with
depression, or that alcohol abuse may have different levels
of comorbidity with anxiety than illicit drug abuse does, the
scarcity of available, population-based, longitudinal studies
on each specific subtype combination prevented us from
making critical distinctions between comorbid patterns.
Studies that compare comorbid patterns between disorder
subtypes across key developmental stages, from childhood
to adulthood, offer a promising way to address this gap.
Third, one of the key questions that remains relates to the
causes of comorbidity: the direction and mechanisms un-
derlying causal links, as well as the potential spurious nature
of such links. Investigating factors at multiple levels of in-
fluence as potential confounders, mediators, triggers, or
modifiers of comorbid associations would enable us to iden-
tify groups at highest risk of the presentation of multiple
disorders and distinguish features of the individual and his
or her environment that are most malleable to preventive
intervention. Moreover, it would enable us to establish
whether associations between comorbid disorders are truly
causal or are spurious phenomena resulting from common
risk factors. Little effort has been invested in systematically
documenting the associations between these disorders
across different age groups or in reviewing the factors asso-
ciated with the cooccurrence of such comorbid forms of
psychopathology. Multilevel multivariate models that con-
sider the joint influence of factors at the individual, family,
and community levels on a set of comorbid disorders pro-
vide a promising avenue to attack the question of common
versus distinct etiologies of comorbid disorders.
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